Applicants often discover better claim language during prototyping or after receiving the First Examination Report. It is natural to ask if claims can be improved or expanded after filing. In India, claim amendments are permitted, but only within carefully policed boundaries. Understanding those boundaries early helps you draft with room to manoeuvre and make timely, compliant amendments when needed.
The statutory framework, in two sections
Section 57 of the Patents Act, 1970, empowers the Controller to allow amendments to the application, complete specification, or related documents before or after grant. Post-grant amendments can be publicised and opposed. Section 57 also permits, in suitable cases, changing the priority date of a claim as part of an amendment.
Section 59 is the gatekeeper. It limits amendments to a disclaimer, correction, or explanation, only to incorporate actual facts. An amendment cannot introduce matter not in substance disclosed earlier, and any amended claim must fall wholly within the scope of a claim as originally filed. In practice, this means amendments must narrow or clarify, and must be traceable to the original disclosure and claim set.
What courts have allowed, and what they have not
Recent Delhi High Court decisions give a practical picture of what “within scope” means.
Nippon A & L Inc v. Controller of Patents (Delhi HC, 2022), the Court permitted converting a product-by-process claim into a process claim where the change narrowed scope and stayed within the original disclosure. Ratio, in one line: narrowing amendments that remain within the disclosed teaching and the filed claim scope are permissible under Section 59.
Allergan Inc v. Controller of Patents (Delhi HC, 2023), the Court set aside a refusal and accepted amendments moving from method-of-treatment framing to product-focused claims because the specification supported the product features and the final claims stayed within the originally disclosed and claimed ambit. Ratio: assess amendments in the context of the entire specification, not snippets, and allow clarificatory narrowing that remains within the claim scope.
AbbVie Biotherapeutics Inc & Anr v. Assistant Controller of Patents & Designs (Delhi HC, 16 April 2025), the Court upheld refusal where applicants sought to recast originally non-patentable method-of-treatment claims into product claims that the Court found went beyond Section 59’s limits. Ratio: you cannot “smuggle in” new product claims post-filing if they enlarge scope or are not anchored in the originally claimed territory.
Cellectis v. Assistant Controller of Patents (Delhi HC, 2025), amendments at the appellate stage were allowed where they operated as a disclaimer or correction within Section 59. Ratio: courts may permit compliant amendments even on appeal, provided they narrow or clarify without adding new matter.
Together, these rulings show a consistent theme: amendments that narrow or clarify and are textually supported by the original specification and sit wholly within the originally filed claim set are viable. Attempts to shift categories or expand to unclaimed territory risk refusal.
When in the lifecycle can you amend?
Before grant
You may file a voluntary amendment using Form 13 at any time after filing, including to respond to the FER. The Controller can also direct amendments, and Section 57 expressly permits you to amend to comply with such directions.
At PCT national phase entry, Indian practice generally allows only deletion of claims at the point of entry. Any other change, including added limitations or category shifts, is typically made by filing Form 13 after entry.
Practical timeline note: since March 2024, the Request for Examination window has shortened to 31 months from the earliest priority, which compresses prosecution. Plan your amendment strategy in sync with this tighter clock.
After grant
Post-grant amendments are still possible via Form 13, but Section 57 allows the Controller to publish the proposed amendment, inviting opposition. Only narrowing or clarificatory amendments pass muster; any enlargement of scope is barred.
Can I add entirely new claims?
Yes, but with caveats. You may add claims, including a new independent claim, only if each amended claim falls wholly within the scope of a claim as originally filed and is grounded in the specification. This is not mere “support in the description”; Section 59 requires the final claim scope to sit inside the originally claimed territory. Courts have allowed reshaping claims that disclaim earlier breadth or clarify with concrete parameters already disclosed, but they have rejected attempts to introduce new product claims where the original set was method-only or where the amendment marked a substantive expansion.
What qualifies as a “disclaimer, correction, or explanation”?
Disclaimer: carving out a subset to narrow scope, for example, specifying a particular range, component, or configuration already disclosed to avoid prior art. Courts recognise disclaimers that reduce claim breadth.
Correction: rectifying errors or infelicities that do not change the invention’s substance.
Explanation: clarifying an ambiguous feature using language anchored in the specification, often adding concrete parameters or relationships that were originally taught.
The key is that the amended claim must remain inside the box drawn by the originally filed claims and disclosure.
Drafting strategy to preserve amendment room
Use drafting to build headroom for later, compliant amendments:
File layered claims, with at least one broad, well-supported independent claim, and meaningful dependent claims as built-in fallbacks with ranges, compositions, and structural features.
Claim across permissible categories that the specification supports, for example, product and process, and avoid relying solely on methods of treatment, which are non-patentable in India under Section 3(i). Courts have been stricter when applicants try to pivot away from method-only claim sets later.
Write a rich specification. Describe alternatives, ranges, and embodiments clearly, so later narrowing amendments read as disclaimers or explanations, not as new matter.
Mind the national phase rule-of-thumb: if you will need structural limitations, include them before filing, since only deletions are typically permitted at entry, and other changes go via Form 13 afterwards.
Procedure and documents for Form 13
What to file: Form 13 with a marked-up copy and a clean copy of the specification or claims, plus a reasoned statement explaining why each amendment qualifies as a disclaimer, correction, or explanation and how it stays within the originally filed claim scope. Official fees apply as per the First Schedule and entity type.
Post-grant: expect publication of the proposed amendment and a window for opposition. Prepare to show that the amendment narrows scope and incorporates only actual facts already disclosed.
Controller’s discretion: the statute vests discretion in the Controller. Well-structured, jurisprudence-backed reasoning improves prospects and can avert an avoidable refusal or a remand on appeal.
Quick answers to common doubts
Can I convert method claims to product claims?
Sometimes. In Allergan (2023), the Court allowed such a shift because the product features were already taught and the final scope stayed within the originally filed claim set. In AbbVie (2025), a similar attempt failed as it effectively broadened scope beyond Section 59. Anchor your amendment in the specification and ensure the amended claim sits inside the original claim territory.
Will amending claims change my priority date?
It can, but only in limited circumstances. Section 57 allows changing the priority date of a claim as part of an amendment, which is why careful mapping of claim features to the priority document is critical.
Can I add claims after the FER?
Yes, via Form 13, provided they function as a disclaimer, correction, or explanation and fall wholly within the scope of the originally filed claims. Cite the specification precisely to show textual support.
Can I amend at the appeal stage?
Yes. The Delhi High Court has permitted compliant amendments even during appeals, where they operated as disclaimers or corrections. Expect the Court to scrutinise Section 59 compliance closely.
Practical takeaways for applicants
Treat Section 59 as a strict filter. Ask, for each proposed change: does it narrow or clarify, and can I point to filed claim text and the specification to prove it is within scope.
Build fallbacks at drafting. A well-layered claim set gives you lawful destinations for later narrowing.
Align timelines. With the RFE window now 31 months, prosecute with amendments in mind, so that FER responses and Form 13 filings are coordinated and timely.
